Latest Breaking News On - Kidney disease improving global outcomes - Page 6 : comparemela.com

Inorganic nitrate reduces contrast-induced nephropathy in high-risk patients

Inorganic nitrate reduces contrast-induced nephropathy (CIN), improves renal outcomes and reduces cardiac events compared to placebo in patients at risk of renal injury undergoing coronary angiography for acute coronary syndrome, according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

City ofUnited kingdomDan jonesDanielle ellisQueen mary university of londonHot lineQueen mary universityKidney disease improving global outcomesCute coronary syndromeAcute kidney injuryChronic kidney diseaseContrast induced nephropathyHeart failureKidney diseaseMyocardial infarctionNitric oxide

Inorganic Nitrate Boosts Safety in High-Risk Angiography Patients

Inorganic Nitrate Boosts Safety in High-Risk Angiography Patients
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomDan jonesQueen mary university of londonHot lineQueen mary universityKidney disease improving global outcomes

Renalytix hails KidneyIntelX inclusion in guidance to evaluate CKD

Renalytix PLC on Monday said its laboratory developed test KidneyIntelX has been included in a draft guidance by Kidney Disease Improving Global Outcomes, a kidney disease-focused organisation. The.

City ofUnited kingdomTom budszusAlliance newsAlliance news ltdKidney disease improving global outcomesAll rights

Detecting Neonatal AKI by Serum Cystatin C : Journal of the American Society of Nephrology

Detecting Neonatal AKI by Serum Cystatin C : Journal of the American Society of Nephrology
lww.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lww.com Daily Mail and Mail on Sunday newspapers.

Significance statementKidney disease improving global outcomes

Real-world evidence highlights the urgent need to act on the growing global burden of chronic kidney disease

AstraZeneca, a leader in cardiorenal diseases, presented new real-world evidence (RWE) data at the European Renal Association (ERA) 2023 Congress in Milan, Italy, demonstrating the staggeringly low rate of diagnosis in chronic kidney disease (CKD). These data show that an urgent need exists for improved screening .

United kingdomUnited statesCompany on twitterEuropean renal associationNational kidney foundationCenters for diseaseUndiagnosed stageAccelerating change togetherExecutive vice presidentBiopharmaceuticals business unitKidney disease improving global outcomesRare diseasesPrevalence of undiagnosed stageKidney disease in australiaCanada andClinical outcomes associated